发明名称 Modulation of androgen receptor expression
摘要 Certain embodiments are directed to compounds and compositions targeted to human androgen receptor (AR) for inhibiting androgen receptor levels in a cell, which can be useful for methods of treating cancer and inhibiting cancer cell growth or proliferation.
申请公布号 US9175291(B2) 申请公布日期 2015.11.03
申请号 US201314050574 申请日期 2013.10.10
申请人 ISIS Pharmaceuticals Inc. 发明人 Macleod Robert A.;Kim Youngsoo;Zhou Tianyuan;Freier Susan M.;Monia Brett
分类号 C12N15/11;C12N15/113;A61K31/7088;A61K31/4166 主分类号 C12N15/11
代理机构 代理人
主权项 1. A compound comprising a single-stranded modified oligonucleotide consisting of 16 linked nucleosides having a nucleobase sequence consisting of the sequence of SEQ ID NO: 35, or a pharmaceutically acceptable salt thereof, wherein the modified oligonucleotide comprises: a gap segment consisting of 9 linked deoxynucleosides; a 5′ wing segment consisting of three linked nucleosides; and a 3′ wing segment consisting of four linked nucleosides;wherein the gap segment is positioned between the 5′ wing segment and the 3′ wing segment; the three linked nucleosides of the 5′ wing segment are each a constrained ethyl (cEt) sugar; the four linked nucleosides of the 3′ wing segment are a constrained ethyl (cEt) sugar, a constrained ethyl (cEt) sugar, a constrained ethyl (cEt) sugar, and a 2′-O-methoxyethyl sugar in the 5′ to 3′ direction; each internucleoside linkage is a phosphorothioate linkage; and each cytosine is a 5-methylcytosine.
地址 Carlsbad CA US